Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
The role of naturally occurring regulatory T cells (Treg), known to be phenotypically heterogeneous, in controlling the expression of systemic lupus erythematosus (SLE) is incompletely defined. Therefore, different subpopulations of CD4(+) FoxP3(+) Tregs in patients with active or inactive SLE were investigated and compared with those of healthy subjects and patients with ankylosing spondylitis (AS). Characterization of different subsets of circulating CD4(+) FoxP3(+) Tregs was examined using flow cytometry. CD4(+) CD25(high) T cells were sorted and examined for suppressive activity in vitro. The results showed first that a significant decrease in the frequency of CD4(+) CD25(high) FoxP3(+) T cells was present in patients with active SLE (n = 58), compared with healthy controls (n = 36) and AS patients (n = 23). In contrast, the frequencies of CD25(low) FoxP3(+) and CD25(-) FoxP3(+) CD4(+) T cells were significantly increased in patients with active SLE by comparison with the control subjects. The elevation of these two putative Treg subpopulations was associated with lower plasma levels of complement C3 and C4 in patients with SLE. In addition, the ratios of the three subsets of CD4(+) FoxP3(+) Tregs versus effector T cells (CD4(+) CD25(+) FoxP3(-)) were inversely correlated with the titer of anti-double-stranded DNA IgG in patients with inactive, but not active, SLE. These results suggest that the pathogenesis of SLE may be associated with a defect in the homeostatic control of different Treg subsets.
Suen
Jau-Ling
JL
Kaohsiung Medical University, Taiwan, China. jlsuen@kmu.edu.tw
Li
Hsiao-Ting
HT
Jong
Yuh-Jyh
YJ
Chiang
Bor-Luen
BL
Yen
Jeng-Hsien
JH
D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000097:blood; D049109:Cell Proliferation; D002478:Cells, Cultured; D004247:DNA / Q000276:immunology; D018450:Disease Progression; D005260:Female; D051858:Forkhead Transcription Factors / Q000032:analysis*; D006706:Homeostasis / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D016130:Immunophenotyping; D053645:Interleukin-2 Receptor alpha Subunit / Q000097:blood; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*; D055815:Young Adult
D000974:Antibodies, Antinuclear; C418974:FOXP3 protein, human; D051858:Forkhead Transcription Factors; D007074:Immunoglobulin G; D053645:Interleukin-2 Receptor alpha Subunit; D004247:DNA
J Immunol. 2001 Aug 1;167(3):1245-53
11466340
J Clin Invest. 2005 Nov;115(11):3276-84
16211090
J Immunol. 2005 Dec 15;175(12):8392-400
16339581
Nat Immunol. 2005 Dec;6(12):1219-27
16244650
Immunology. 2006 Feb;117(2):280-6
16423064
Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6659-64
16617117
Blood. 2006 May 15;107(10):3940-9
16410445
Br J Pharmacol. 2006 Jun;148(3):245-54
16604091
J Exp Med. 2006 Jul 10;203(7):1693-700
16818676
J Exp Med. 2006 Jul 10;203(7):1701-11
16818678
Immunol Rev. 2006 Aug;212:149-62
16903912
Blood. 2006 Nov 15;108(10):3371-8
16868256
J Immunol. 2007 Feb 15;178(4):2579-88
17277168
Nat Med. 2007 Nov;13(11):1299-307
17922010
J Exp Med. 2003 Dec 15;198(12):1875-86
14676299
Immunity. 2002 Feb;16(2):311-23
11869690
Immunity. 2002 Apr;16(4):535-46
11970877
Nat Rev Immunol. 2003 Mar;3(3):253-7
12658273
Curr Opin Rheumatol. 2003 Jul;15(4):430-5
12819471
J Autoimmun. 2003 Nov;21(3):273-6
14599852
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15059-64
14608036
Scand J Immunol. 2004 Feb;59(2):198-202
14871297
J Exp Med. 2004 Apr 5;199(7):971-9
15067033
J Exp Med. 2004 May 3;199(9):1285-91
15117972
Arthritis Rheum. 2004 Sep;50(9):2775-85
15457445
J Immunol. 2004 Oct 15;173(8):5008-20
15470044
Ann N Y Acad Sci. 1997 Apr 5;815:1-14
9186635
Arthritis Rheum. 1997 Sep;40(9):1725
9324032
J Pharmacol Exp Ther. 1998 Jul;286(1):191-200
9655860
Hum Immunol. 2005 Jan;66(1):13-20
15620457
Nat Immunol. 2005 Apr;6(4):338-44
15785759
Nat Immunol. 2005 Apr;6(4):345-52
15785760
J Clin Invest. 2005 Jul;115(7):1953-62
16007258
Curr Opin Immunol. 2005 Dec;17(6):638-42
16209918
Nat Immunol. 2002 Feb;3(2):135-42
11812990